Since hnRNPA1 is a MNK effector [36], and is inhibited by Quercetin in prostate cancer cells [29], we evaluated whether hnRNPA1 knockdown also enhances the anti-tumor effects of BET inhibitors. Here, ATP7A is linked to neoplasm.